CONSOLIDATED EDISON INC (ED) Stock News

Rosen Law Firm is soliciting investors for multiple securities class action lawsuits. The primary case involves Dun & Bradstreet Holdings, alleging false and misleading statements regarding a merger with Clearlake Capital Group, including omissions about executive interests and financial advisor conflicts. Additional cases involve Duolingo, Inc. and XTI Aerospace, Inc. The lead plaintiff deadline for the DNB case is November 10, 2026.

Rosen Law Firm is urging Duolingo investors who purchased stock between May 2, 2025 and February 26, 2026 to join a securities class action lawsuit. The lawsuit alleges that Duolingo made false statements about user growth by concealing that increased monetization efforts, ad volume, and lower-quality AI-generated content were negatively impacting daily active users and product quality. The lead plaintiff deadline is December 7, 2026.

Rosen Law Firm has filed a securities class action lawsuit against Celsius Holdings, Inc. (CELH) on behalf of investors who purchased securities between February 21, 2025 and June 3, 2026. The lawsuit alleges that Celsius made materially false and misleading statements regarding the cardiac risks of its Alani Nu products and inappropriately marketed these products to consumers under 18 years old. The lead plaintiff deadline is November 3, 2026.

Rosen Law Firm is reminding investors who purchased Qfin Holdings securities between March 18, 2026 and August 25, 2026 of an important November 30, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Qfin made false and misleading statements about the resiliency of its business and downplayed the negative impact of regulatory headwinds on its financial results.

Rosen Law Firm is urging FuelCell Energy (FCEL) investors who purchased securities between June 24, 2026 and September 1, 2026 to join a class action lawsuit. The lawsuit alleges that FuelCell made false statements about its business, concealing inadequate manufacturing capacity, slower production rates, higher costs, and likely CEPA-related charges that materially misled investors. The lead plaintiff deadline is November 10, 2026.

Rosen Law Firm announces a securities class action lawsuit against Hims & Hers Health, Inc. for allegedly making false statements about data privacy practices and billing procedures. The lawsuit claims Hims shared consumer health information with third-party advertisers and charged for prescriptions immediately despite promising consultations with medical providers. Investors who purchased HIMS securities between August 4, 2025 and July 29, 2026 may be eligible for compensation. The lead plaintiff deadline is November 2, 2026.

SEDA Experts LLC announced that Noor Ul Islam joined as Managing Director. With nearly 30 years of experience in trading and risk management at major financial institutions including Citibank and Barclays, Islam brings expertise in counterparty credit risk, market risk, and structured derivatives to strengthen SEDA's risk management and securities practices.

The FDA has approved Roche's Enspryng (satralizumab) as the first at-home subcutaneous treatment for thyroid eye disease (TED). The approval was based on Phase III SatraGO-1 and -2 studies, with SatraGO-2 demonstrating significant reductions in eye bulging (proptosis) and improvements in double vision (diplopia). Enspryng is an IL-6R inhibitor using novel recycling antibody technology and represents the second indication for the drug, following its 2020 approval for neuromyelitis optica spectrum disorder (NMOSD).

Rosen Law Firm is urging investors who purchased Lincoln Educational Services Corporation (LINC) securities between May 11, 2026 and August 9, 2026 to join a class action lawsuit before the November 10, 2026 deadline. The lawsuit alleges that defendants made false statements about the company's admissions process and student conversion rates, claiming the company experienced a significant drop in student starts relative to enrollment, making positive statements about the business materially misleading.

Rosen Law Firm is notifying Beta Bionics, Inc. investors of a November 3, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Beta Bionics made false statements about its iLet Bionic Pancreas insulin pump, which the FDA found to be malfunctioning and causing dangerously high insulin dosing. The company allegedly failed to implement meaningful corrective actions despite thousands of complaints and hundreds of life-threatening events.

Rosen Law Firm has filed a class action lawsuit against Duolingo, Inc. on behalf of investors who purchased Class A common stock between May 2, 2025 and February 26, 2026. The lawsuit alleges that Duolingo made materially false statements regarding Daily Active User growth, failed to disclose that increased user friction from ads and subscription upsells was negatively impacting DAU growth, and that low-quality AI-generated content was degrading the product experience and user retention. The lead plaintiff deadline is December 7, 2026.

Rosen Law Firm is reminding Flotek Industries investors who purchased securities between August 3-17, 2026 of the October 26, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Flotek made materially false statements regarding a Puerto Rico Electric Power Authority contract, failing to disclose credible doubts about the consortium's capacity to execute the project, which posed risks to revenue realization.

Rosen Law Firm is notifying investors of Qfin Holdings who purchased securities between March 18, 2026 and August 25, 2026 of an important November 30, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Qfin defendants made false and misleading statements regarding the resiliency of the company's business and downplayed the negative impact of regulatory headwinds on financial results.

Rosen Law Firm has filed securities class action lawsuits against FuelCell Energy, Hyliion Holdings, and Tigo Energy, alleging that defendants made false and misleading statements regarding their business operations and financial prospects. Investors who purchased securities during specified class periods are encouraged to secure counsel before upcoming deadlines, with the FuelCell case having a November 10, 2026 lead plaintiff deadline.

SolarEdge Technologies (SEDG) declined 6.18% to $30.52, underperforming the S&P 500's 1.11% loss. The stock has dropped 7.74% over the past month, lagging the sector's gains. While the company is forecasted to report EPS of $0.01 (up 103.23% YoY), revenue is expected to decline 3.25% to $329.11 million. SEDG holds a Zacks Rank #3 (Hold) rating, with the Solar industry ranking in the bottom 15% of all industries.

MiMedx Group, Inc. announced it will report Q3 2026 financial results on October 28, 2026, followed by a webcast and conference call at 4:30 p.m. ET. The company also announced a favorable federal court ruling vacating FDA determinations regarding AXIOFILL's regulatory classification as a biological product.

The First Trust Dow 30 Equal Weight ETF (EDOW) is a passively managed large-cap blend ETF with $316.89 million in assets and a 0.5% expense ratio. It has delivered 10.59% returns year-to-date and 15.98% over the past year, with a Zacks ETF Rank of 3 (Hold). However, larger competitors like the iShares Core S&P 500 ETF and Vanguard 500 Index Fund offer significantly lower expense ratios of 0.03% and substantially larger asset bases.

Rosen Law Firm announces securities class action lawsuits against Papa John's International (PZZA) and other companies. The Papa John's lawsuit alleges the company made materially false statements about its transformation efforts, concealing that the process was taking longer than expected and failing to prevent market share losses. Investors who purchased stock during the class period may be eligible for compensation. The lead plaintiff deadline is November 2, 2026.

Medpace (MEDP) closed down 1.64% and currently holds a Zacks Rank #3 (Hold) rating. The stock trades at a Forward P/E of 35.35, significantly above the industry average of 17.86, and a PEG ratio of 2.77 versus the industry average of 1.67. While earnings are expected to grow 15.28% next quarter and 14.79% for the full year, the premium valuation suggests limited upside potential in the near term.

Rosen Law Firm has filed class action lawsuits on behalf of investors in Coastal Financial Corporation (CCB) for alleged misrepresentation of credit risks associated with its CCBX business. The firm is seeking lead plaintiffs with a December 1, 2026 deadline. Investors who purchased CCB stock between October 28, 2024 and July 29, 2026 may be eligible for compensation.

Rosen Law Firm has filed a class action lawsuit against Alphabet Inc. on behalf of investors who purchased securities between May 19, 2026 and July 16, 2026. The lawsuit alleges that Alphabet made materially false and misleading statements regarding the Gemini 3.5 Pro, claiming it delivered disappointing training results and would face significant launch delays. Investors who wish to serve as lead plaintiff must file by December 1, 2026.

Crédit Agricole has signed an agreement to acquire 100% of IKB Deutsche Industriebank AG from Lone Star Funds for €14.3 billion in total assets. The acquisition is a strategic move to accelerate Crédit Agricole's expansion in Germany's mid-corporate banking market, particularly targeting the Mittelstand. The transaction is expected to close by end of Q2 2027 and will have a negative impact of approximately 20 basis points on Crédit Agricole's CET1 ratio.

Crédit Agricole has signed an agreement to acquire 100% of IKB Deutsche Industriebank AG from Lone Star Funds, marking a major expansion of its German operations. The acquisition will strengthen Crédit Agricole's presence in the mid-market segment (ETI) and support its ACT 2028 strategic plan. The transaction is expected to close by end of Q2 2027 and will have a negative impact of approximately 20 basis points on Crédit Agricole's CET1 ratio.

Rosen Law Firm has filed a class action lawsuit on behalf of Duolingo investors who purchased Class A common stock between May 2, 2025 and February 26, 2026. The lawsuit alleges that Duolingo made materially false statements regarding user growth, failed to disclose that increased monetization efforts and ad friction were negatively impacting daily active users, and that AI-generated content was degrading product quality. Investors must move the court by December 7, 2026 to serve as lead plaintiff.

Rosen Law Firm is reminding investors who purchased Unicycive Therapeutics securities between December 29, 2025 and June 29, 2026 about the November 2, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Unicycive made materially false statements regarding its third-party manufacturing vendor's FDA compliance and failed to disclose risks of regulatory delays for its oxylanthanum carbonate drug candidate.

Rosen Law Firm is notifying investors in Aardvark Therapeutics, Inc. of an October 13, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Aardvark made materially false and misleading statements regarding the safety and prospects of its drug ARD-101, and failed to disclose material adverse facts about the company's business and operations.

Rosen Law Firm is reminding investors in Anavex Life Sciences, Ardelyx, and AST SpaceMobile to join securities class action lawsuits before upcoming deadlines. The lawsuits allege that these companies made false or misleading statements regarding their business operations, internal controls, and regulatory challenges. Investors who purchased securities during specified class periods may be entitled to compensation.

Rosen Law Firm is soliciting investors who purchased securities of Ardelyx, Inc., Anavex Life Sciences Corp., and AST SpaceMobile, Inc. during specified periods to join class action lawsuits. The firm alleges these companies made materially false statements regarding commercial performance and growth prospects. Investors have until November 16, 2026 to serve as lead plaintiffs.

EXEED Automobile announces its 2026 International User Summit scheduled for October 18-23 in China under the theme 'The Pulse Lives on.' The company has surpassed 550,000 users across 60+ markets and celebrates the fifth anniversary of EXEEDers Club. Throughout 2026, EXEED has expanded its global presence through strategic partnerships, sponsorships, and brand events across Europe, Africa, and Eastern Europe, while introducing new design languages and vehicle concepts including the MPV CONCEPT and ET9.

Rosen Law Firm is urging investors in York Space Systems Inc. (NYSE: YSS) to join a securities class action lawsuit before the October 30, 2026 deadline. The lawsuit alleges that York Space made materially false statements about its business operations, specifically regarding incomplete onboard mission and payload software on satellites delivered to the Pentagon's Space Development Agency, and that the company misled investors about its prospects.